Skip to main content
Caplight Logo









Cresilon

Cresilon

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://cresilon.com/

Last Round

Seed Round

Apr 29, 2026

Est. Valuation

$93.5M

Total Funding Raised

$97.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary plant-based hydrogel technology to control bleeding.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hemostatic geltrauma carehemostatic devicebleeding controlsurgical bleedingstop bleedinghydrogel technologyhemorrhage controlveterinary medicinewound caremedical deviceemergency medicinebiotechsurgical suppliestrauma kit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cresilon Comparables

Compare Cresilon with similar companies based on industry and business-model similarity.

Cresilon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zomedica Corp.
91%
Axio Biosolutions
83%
Medcura, Inc.
83%

Cresilon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 29, 2026
VC RoundSep 9, 2025
Series AApr 11, 2025
Series A-4Oct 27, 2022
Series A ExtensionApr 8, 2021
Series A Extension
Jan 22, 2019

Key People

Founding team and executive leadership

David Sigona MCGI

Director Of Security (CEO Board), Buisness Development Consultant - SME Military Pre Hospital Emergency Care

Executive Team

Joe Landolina

Chief Executive Officer and Co-Founder

Founding Team

Cresilon Investors

Notable investors and investment history

Cresilon investors
InvestorRounds
Paulson Investment CompanySeries A, Series A-4
Catalio Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 165% MoM, reaching 10.1K.

  • Apr 29, 2026

    Raised $5M in seed funding.

Cresilon Filings

Explore SEC and related filing metadata, where available.

Cresilon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cresilon's valuation, stock price, and market status.

Is Cresilon a public or private company?

Cresilon is a private company.

What is the current stock price of Cresilon?

Cresilon is a private company with no public stock price. No recent secondary market data is available.

How much is Cresilon worth (valuation)?

Valuation information for Cresilon is not publicly available.

Can I buy Cresilon stock?

Cresilon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cresilon's last funding round?

Cresilon's most recent funding round was Seed Round on April 29, 2026.

Who are the main investors in Cresilon?

Key investors in Cresilon include Paulson Investment Company.

Will Cresilon IPO soon?

No public IPO plans have been announced for Cresilon.

How can I track Cresilon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cresilon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range68
Year Founded2010
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?